Imirestat (AL 1576) |
Katalog-Nr.GC31412 |
Imirestat (AL 1576) (AL 1576) ist ein Aldose-Reduktase-Hemmer, der zur Behandlung von Diabetes eingesetzt wird.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 89391-50-4
Sample solution is provided at 25 µL, 10mM.
Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.
Imirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in insulin-stimulated oubain-sensitive ATPase activity[1].
[1]. Carrington AL, et al. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Diabetologia. 1991 Jun;34(6):397-401.
Average Rating: 5
(Based on Reviews and 8 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *